uch attention has been paid to proteinuria and renal dysfunction in obese people without diabetes mellitus (DM) as obesity-related glomerulopathy (ORG). The Adults Treatment Panel III (ATP) of the National Cholesterol Education Program, based on data in the United States, defined obesity as a body mass index (BMI) of ≥30 kg/m; however, the Japan Society for the Study of Obesity reported that ob...

Background: The prevalence of metabolic syndrome (MetS) is increasing worldwide. Limited data are available trying to compare different definitions suggested to identify MetS. This study aimed to compare the prevalence of MetS and its components based on currently available international and Iranian national definitions. Methods: The present cross-sectional study was conducted in 2015 amongfema...

background: the prevalence of metabolic syndrome (mets) is increasing worldwide. limited data are available trying to compare different definitions suggested to identify mets. this study aimed to compare the prevalence of mets and its components based on currently available international and iranian national definitions. methods: the present cross-sectional study was conducted in 2015 amongfema...

background: the prevalence of metabolic syndrome (mets) is increasing worldwide. limited data are available trying to compare different definitions suggested to identify mets. this study aimed to compare the prevalence of mets and its components based on currently available international and iranian national definitions. methods: the present cross-sectional study was conducted in 2015 among fem...

BACKGROUND Non-HDL-C as a valuable predictor of premature atherosclerosis, coronary events like first Myocardial infarction and cardiovascular mortality has a high accuracy of measurement both in fasting and non-fasting individuals. Metabolic syndrome (MetS) can promote the development of diabetes mellitus, endothelial dysfunction and atherosclerosis. A common pathway for cross linking of metab...

BACKGROUND Metabolic syndrome (MetS) is used as a clinical tool to identify individuals at risk of cardiovascular disease (CVD) but its clinical value in the management of type 2 diabetes mellitus (T2DM) remains uncertain. AIM To determine the prevalence and clinical usefulness of MetS among patients with T2DM attending diabetes clinics in a large teaching hospital. DESIGN Prospective obser...

OBJECTIVE From the emergence of different definitions of metabolic syndrome (MS) we aim to determine the prevalence of such a condition among hypertensive Saudi population and to identify which definition can best assess the risk of hyperhomocysteinemia, coronary heart disease (CHD), and diabetes mellitus. METHODS In this cross-sectional study, we studied 581 hypertensive Saudis, aged 21-70, ...

BACKGROUND In HIV-infected patients, combination antiretroviral therapy (cART) is associated with clinical lipodystrophy (CL) and metabolic abnormalities (MA). This study aimed to evaluate the prevalence of the metabolic syndrome (MS) and its components, and to determine whether patients with or without CL had a different prevalence of MA. METHODS We evaluated 345 HIV-infected patients on cAR...